Non-invasive screening device for neonatal jaundice

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220215006

Enrollment

220

Registered

2022-02-15

Start date

2022-02-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonates with gestational age at least 30 weeks with jaundice Jaundice, preterms, term

Interventions

Participants will be measured bilirubin level by a non-invasive screening device invested by authors, the results will be compared with standard measurement (Microbilirubin)

Diagnostic

Jaundice screening by non-invasive screening device

Eligibility

Sex/Gender

All

Age

1 Days to 28 Days

Inclusion criteria

Inclusion criteria: 1. Preterms with gestational age at least 30 weeks with jaundice, with chronological age less than or equal 28 days 2. Term newborns with jaundice with chronological age less than or equal 28 days

Exclusion criteria

Exclusion criteria: 1. Skin infection 2. Cyanotic heart disease

Design outcomes

Primary

Measure	Time frame
Bilirubin level 12 months mg/dL	—

Secondary

Measure	Time frame
Safety 3 days Safety,visual assessment by healthcare providers at the time of measurement bilirubin yes/no and zone of jaundice	—

Countries

Thailand

Contacts

Public ContactNanthida Phattraprayoon

Chulabhorn Royal Acedemy

nanthida.pha@cra.ac.th0886247388

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026